{"id":"idp-110","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-15%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Vomiting"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"IDP-110 works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, reducing glucose reabsorption and lowering blood glucose levels. This mechanism is particularly effective in treating type 2 diabetes.","oneSentence":"IDP-110 is a small molecule that targets the SGLT2 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:15:31.160Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT00664248","phase":"PHASE3","title":"A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris","status":"COMPLETED","sponsor":"Dow Pharmaceutical Sciences","startDate":"2006-10","conditions":"Acne Vulgaris","enrollment":1414},{"nctId":"NCT00663286","phase":"PHASE3","title":"A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris","status":"COMPLETED","sponsor":"Dow Pharmaceutical Sciences","startDate":"2006-10","conditions":"Acne Vulgaris","enrollment":1399}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"IDP-110","genericName":"IDP-110","companyName":"Dow Pharmaceutical Sciences","companyId":"dow-pharmaceutical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IDP-110 is a small molecule that targets the SGLT2 receptor. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}